BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Megestrol 160mg/5ml oral suspension 0803020L0AAACAC	Megestrol acetate	Megestrol acetate	Malignant Disease and Immunosuppression	2
Melatonin 4mg capsules 0401010ADAAAUAU	Melatonin	Melatonin	Central Nervous System	2
Melatonin 8mg capsules 0401010ADAABJBJ	Melatonin	Melatonin	Central Nervous System	2
Melgisorb dressing 10cm x 20cm 20030200082	Melgisorb dressing 10cm x 20cm	Wound Management & Other Dressings	Dressings	2
Melphalan 2mg tablets 0801010S0AAABAB	Melphalan	Melphalan	Malignant Disease and Immunosuppression	2
Menopur 600unit inj vials 0605010N0BFABAG	Menopur	Menotrophin	Endocrine System	2
Menthol 4% in Aqueous cream 1303000AAAAAUAU	Menthol (Topical)	Menthol	Skin	2
Meprobamate 400mg tablets 0401020R0AAABAB	Meprobamate	Meprobamate	Central Nervous System	2
Meptazinol 100mg/1ml solution for injection ampoules 0407020L0AAAAAA	Meptazinol hydrochloride	Meptazinol hydrochloride	Central Nervous System	2
Meptid 100mg/1ml solution for injection ampoules 0407020L0BBABAA	Meptid	Meptazinol hydrochloride	Central Nervous System	2
Mesna 400mg tablets 0801000T0AAACAC	Mesna (Cancer)	Mesna	Malignant Disease and Immunosuppression	2
Methadose diluent oral solution sugar free 190700000BBBPBJ	Proprietary compound preparation BNF 1907000	Other base/diluent/suspending agent/stabiliser preparations	Other Drugs and Preparations	2
Methofill 30mg/0.6ml inj pre-filled injector 1001030U0BGAJCA	Methofill (Rheumatism)	Methotrexate	Musculoskeletal and Joint Diseases	2
Methofill 30mg/0.6ml inj pre-filled syringes 1001030U0BGATBJ	Methofill (Rheumatism)	Methotrexate	Musculoskeletal and Joint Diseases	2
Methotrexate 12.5mg/5ml oral liquid 1001030U0AAAKAK	Methotrexate (Rheumatism)	Methotrexate	Musculoskeletal and Joint Diseases	2
Methotrexate 20mg/2ml inj pre-filled syringes 1001030U0AABABA	Methotrexate (Rheumatism)	Methotrexate	Musculoskeletal and Joint Diseases	2
Methotrexate 5mg/2ml solution for injection vials 0801030P0AAAIAI	Methotrexate	Methotrexate	Malignant Disease and Immunosuppression	2
Methoxy polyethylene glycol-epoetin beta 120microg/0.3ml inj 0901030N0AAAHAH	MPEG-Epoetin Beta	Methoxy polyethylene glycol-epoetin beta	Nutrition and Blood	2
Methoxy polyethylene glycol-epoetin beta 30microg/0.3ml inj 0901030N0AAAGAG	MPEG-Epoetin Beta	Methoxy polyethylene glycol-epoetin beta	Nutrition and Blood	2
Metolazone 2.5mg/5ml oral liquid 0202010V0AAAKAK	Metolazone	Metolazone	Cardiovascular System	2
Mevalia low protein choco chip biscuits 0904010Z0BJAAAA	Mevalia (Gluten free low protein biscuits)	Gluten free/low protein biscuits	Nutrition and Blood	2
Mexiletine 100mg tablets 0203020P0AAAMAM	Mexiletine hydrochloride	Mexiletine hydrochloride	Cardiovascular System	2
Microair Barrier gloves 21011300114	Microair Barrier gloves	Other Appliances	Appliances	2
microINR testing strips 0208020W0BGAAA0	microINR (Reagent)	INR blood testing reagents	Cardiovascular System	2
Micronor 350microgram tablets 0703021N0BBAAAA	Micronor	Norethisterone	Obstetrics, Gynaecology and Urinary-Tract Disorders	2

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.